• Home
  • About Us
    • Company Profile
    • Corporate Structure
    • Milestones
  • Core Business
    • R&D and Production Base
      • Zhuhai R&D and Production Base
      • Kunming R&D and Production Base
      • Global Sales Network
    • Chinese Medicine Development
      • Chinese Medicine R&D
      • Chinese Medicinal Materials
      • Decoction Slices
    • Biomedical Technology and Products
      • Tianda Products
      • Pipeline
    • Quality Healthcare Services
  • Investor Relations
    • Corporate Information
    • Corporate Governance
    • Announcements & Circulars
    • Financial Statements
    • Shares and Details
    • Investor Calendar
    • Investor Enquiries
    • Email Alerts
    • Notices (Replacement of Lost Share Certificates)
    • Dissemination of Corporate Communications
  • Sustainability
    • Our Sustainable Development
    • ESG Report
  • Careers
    • Wort At Tianda
    • Recruitment
      • Vacancies
      • Internship Programmes
      • Trainee Programmes
  • Media Centre
    • Press Releases
    • Media Coverage
    • Contact Us
    • 繁
    • 简
繁 简
  • About Us
    • Company Profile
    • Corporate Structure
    • Milestones
  • Core Business
    • R&D and Production Base
      • Zhuhai R&D and Production Base
      • Kunming R&D and Production Base
      • Global Sales Network
    • Chinese Medicine Development
      • Chinese Medicine R&D
      • Chinese Medicinal Materials
      • Decoction Slices
    • Biomedical Technology and Products
      • Tianda Products
      • Pipeline
    • Quality Healthcare Services
  • Investor Relations
    • Corporate Information
    • Corporate Governance
    • Announcements & Circulars
    • Financial Statements
    • Shares and Details
    • Investor Calendar
    • Investor Enquiries
    • Email Alerts
    • Notices (Replacement of Lost Share Certificates)
    • Dissemination of Corporate Communications
  • Sustainability
    • Our Sustainable Development
    • ESG Report
  • Careers
    • Wort At Tianda
    • Recruitment
      • Vacancies
      • Internship Programmes
      • Trainee Programmes
  • Media Centre
    • Press Releases
    • Media Coverage
    • Contact Us

2013
  • Select Year
    1. 2022
    2. 2021
    3. 2020
    4. 2019
    5. 2018
    6. 2017
    7. 2016
    8. 2015
    9. 2014
    10. 2013
    11. 2012
  • 28.11.2013

    【東方日報】天大藥業純利跌35% (Chinese version only)

  • 28.11.2013

    【大公報】天大藥業擬倍增銷售人員 (Chinese version only)

  • 28.11.2013

    【香港商報】天大藥業: 珠海廠擬搬遷 (Chinese version only)

  • 28.11.2013

    【新報】天大藥業核心盈利升四成 (Chinese version only)

  • 28.11.2013

    【東方電視】天大藥業擬拓東南亞及本港市場 (Chinese version only)

  • 27.11.2013

    【經濟通】天大藥業中期少賺35﹒7%至1580萬,不派息 (Chinese version only)

  • 27.11.2013

    【阿思達克財經網】天大藥業(00455.HK)中期純利1580萬 跌36% (Chinese version only)

  • 27.11.2013

    【和訊網】天大藥業: 有意開拓東南亞及本港市場 (Chinese version only)

  • 27.11.2013

    【經濟通】天大藥業(00455)中期少賺36%,惟價漲近9% (Chinese version only)

  • 27.11.2013

    【阿思達克財經網】天大藥業(00455.HK)澳洲產品最快本月底在港上市 (Chinese version only)

  • 27.11.2013

    【經濟通】天大:澳洲保健業務未有盈利貢獻,將推網上銷售平台 (Chinese version only)

  • 27.11.2013

    【騰訊網】天大藥業: 有意開拓東南亞及本港市場 (Chinese version only)

  • 27.11.2013

    【信報】天大藥業半年純利跌35% (Chinese version only)

  • 27.11.2013

    【騰訊網】天大藥業: 有意開拓東南亞及本港市場 (Chinese version only)

  • 26.11.2013

    【新城廣播】天大藥業半年純利按年跌 35.7%不派息 (Chinese version only)

  • 24.10.2013

    【經濟日報】注資指日可待 天大爆升可期 (Chinese version only)

  • 23.08.2013

    【信報】天大藥業 「燒冷灶」(Chinese version only)

  • 02.08.2013

    【星島日報】天大藥業小注冷敲 (Chinese version only)

  • 29.07.2013

    【文匯報】天大藥業具追落後潛力 (Chinese version only)

  • 18.07.2013

    【資本創富】巡廠面面觀 - 天大藥業 (Chinese version only)

  • 02.07.2013

    【新報】天大藥業逢低收集 (Chinese version only)

  • 27.06.2013

    【星島日報】天大研發新藥料有睇頭 (Chinese version only)

  • 26.06.2013

    【大公報】天大藥業盈利減12% (Chinese version only)

  • 26.06.2013

    【新報】天大藥業反彈未完 (Chinese version only)

  • 26.06.2013

    【信報】天大藥業全年少賺12.5% (Chinese version only)

  • 26.06.2013

    【星島日報】天大冀主攻生物醫藥業務 (Chinese version only)

  • 26.06.2013

    【頭條日報】天大藥業(455)公佈截至今年3月底全年業績 (Chinese version only)

  • 25.06.2013

    【ETNet】天大藥業全年少賺12%至3774萬,息0.41仙 (Chinese version only)

  • 25.06.2013

    【Finet】天大藥業(0455-HK)全年純利跌12.43%至3,774.01萬元,末期息0.41仙 (Chinese version only)

  • 25.06.2013

    【Tencent】天大藥業(00455.HK)全年少賺12% 派末期 息0.41仙 (Chinese version only)

  • 25.06.2013

    【Tencent】天大藥業(00455.HK)對今年產品價格審慎樂觀 冀毛利率維持(Chinese version only)

  • 25.06.2013

    【爽報】天大藥業4億現金覓收購 (Chinese version only)

  • 25.06.2013

    【Apple Daily】天大藥業4億現金覓收購 (Chinese version only)

  • 22.05.2013

    【大公報】天大藥業潛質優厚 (Chinese version only)

  • 06.05.2013

    【星島日報】拓保健食品 – 天大藥業有錢途 (Chinese version only)

  • 03.05.2013

    【新報】天大藥業質優可取 (Chinese version only)

  • 25.04.2013

    【文匯報】天大購澳企擴健康產品 (Chinese version only)

  • 25.04.2013

    【星島日報】天大藥業拓澳分銷渠道 (Chinese version only)

  • 25.04.2013

    【經濟日報】天大藥業完成收購 (Chinese version only)

  • 25.04.2013

    【新報】天大藥業千萬購澳企 (Chinese version only)

  • 25.04.2013

    【Apple Daily】天大藥業物色內地併購 (Chinese version only)

  • 25.04.2013

    【香港商報】天大藥業收購澳企 (Chinese version only)

  • 25.04.2013

    【大公報】天大藥業拓澳洲銷售網 (Chinese version only)

  • 24.04.2013

    【Sina】天大藥業將整頓收購的澳洲健康產品業務 (Chinese version only)

  • 24.04.2013

    【ETNet】天大藥業:斥逾千萬購澳洲健康產品公司,未來續併購無資金壓力 (Chinese version only)

  • 24.04.2013

    【Tencent】天大藥業1010萬購澳醫藥公司 (Chinese version only)

  • 24.04.2013

    【匯港通訊】天大藥業收購澳洲Cynergy Health業務 拓展健康產品國際市場 (Chinese version only)

關注天大藥業:

  • About Us
    Company Profile Corporate Structure Milestones
  • Core Business
    R&D and Production Base Chinese Medicine Development Biomedical Technology and Products Quality Healthcare Services
  • Investor Relations
    Corporate Information Corporate Governance Announcements & Circulars Financial Statements Shares and Details Investor Calendar Investor Enquiries Email Alerts Notices (Replacement of Lost Share Certificates) Dissemination of Corporate Communications
  • Sustainability
    Our Sustainable Development ESG Reports
  • Careers
    Wort At Tianda Recruitment
  • Media Centre
    Press Releases Media Coverage Contact Us

Email AlertsPlease enter your email address

關注天大藥業:

  • Hong Kong Headquarters Level 24, CITIC Tower, No. 1 Tim Mei Avenue, Central, Hong Kong

    Tel: +852 2545 3313

    Fax: +852 2541 6558

    Email: info@tianda.com

  • China, Regional Headquarters Level 28, Block C, Tian An International Building, 3012 Renmin Road South, Shenzhen, China

    (Postal code: 518001)

    Tel: +86 755 8228 3533

    Fax: +86 755 8228 9636

  • Australia, Regional HeadquartersSuite 3.03, Level 3, Macquarie Corporate Centre, 2 Banfield Road, Macquarie Park, NSW 2113, Australia

    Tel: +61 2 9251 9001

    Fax: +61 2 9251 7688

© Tianda Pharmaceuticals Limited. All Rights Reserved.
Disclaimer | Important Notice